Zobrazeno 1 - 10
of 68
pro vyhledávání: '"B Cottier"'
Autor:
B. Cottier, Graeme J. Poston, Philip Quirke, Lesley Fairley, E F Taylor, James Thomas, David Forman, Eva Morris
Publikováno v:
British Journal of Surgery. 97:1110-1118
Background This population-based study investigated the frequency of hepatic resections for colorectal cancer metastases across England and their outcome. Methods Individuals who underwent surgery for colorectal cancer between January 1998 and June 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6bdca8eb6fb24e9f59414f7fbd2b50f4
https://doi.org/10.1002/bjs.7032
https://doi.org/10.1002/bjs.7032
Publikováno v:
Clinical Oncology. 15:41-46
To undertake a national audit of radiotherapy practice in head and neck cancer to estimate compliance with published guidelines and national standards.A two-part electronic data entry form was distributed to all U.K. radiotherapy centres in September
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3ce31a379cf1408ad84807c9f8a0475
https://doi.org/10.1053/clon.2002.0198
https://doi.org/10.1053/clon.2002.0198
Autor:
M B McIllmurray, J Carmichael, Robert Milroy, Paul A Burt, Nick Thatcher, S. Falk, M G Bond, Tim Maughan, Penelope Hopwood, C K Connolly, B Cottier, M Nicholson, Richard Stephens, Heather Anderson
Publikováno v:
British Journal of Cancer
Three hundred patients with symptomatic, locally advanced or metastatic NSCLC not requiring immediate radiotherapy were enrolled into this randomized multicentre trial comparing gemcitabine + BSC vs BSC alone. Patients allocated gemcitabine received
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3afda200d2abbedf4341907babb3e304
http://europepmc.org/articles/PMC2374661
http://europepmc.org/articles/PMC2374661
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 33:195-199
Purpose : The use of endobronchial brachytherapy in the treatment of lung cancer is increasing due to the more widespread availability of high dose rate afterloading equipment. The complications include small airway (segmental and small lobar bronchi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8cee1f4b83fbe02963640fa10f5a587
https://doi.org/10.1016/0360-3016(94)00650-a
https://doi.org/10.1016/0360-3016(94)00650-a
Autor:
Wilson M. Compton, Edward L. Spitznagel, Doug E. Mager, Linda B. Cottier, Gregory Asmus, Stephen H. Dinwiddie
Publikováno v:
American Journal on Addictions. 3:263-272
Volatile inhalant use has previously been shoum to be associated with psychiatric illness and use of other substances. The authors examined the association of history of inhalant use with other drug use, psychiatric disorders, and sociodemographic ch
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0498c33ef1a0bc856a04cde3f50c8b27
https://doi.org/10.3109/10550499409117261
https://doi.org/10.3109/10550499409117261
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Clinical oncology (Royal College of Radiologists (Great Britain)). 20(8)
Aims To re-audit national radiotherapy practice in head and neck cancer to assess the effect of new guidelines. Materials and methods A two-part electronic audit assessing departmental policies and the management of interruptions was carried out from
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1bb90427ec4c651b2cff19fadc4d5e6d
https://pubmed.ncbi.nlm.nih.gov/18555671
https://pubmed.ncbi.nlm.nih.gov/18555671
Autor:
T, Le Chevalier, M, Gottfried, U, Gatzemeier, F, Shepherd, P, Weynants, B, Cottier, H J, Groen, R, Rosso, K, Mattson, H, Cortes-Funes, M, Tonato, R L, Burkes, M, Voi, A, Ponzio
Publikováno v:
Bulletin du cancer. 84(3)
Gemcitabine is a novel pyrimidine nucleoside whose activity has been demonstrated on solid tumors. We report here the results of a multicentre phase II trial of gemcitabine in chemonaive patients with inoperable non small cell lung cancer (NSCLC). Ge
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e218f23f828bf15590d3d711a3435309
https://pubmed.ncbi.nlm.nih.gov/9207875
https://pubmed.ncbi.nlm.nih.gov/9207875
Autor:
T. Le Chevalier, U. Gatzemeier, Karin Mattson, Harry J.M. Groen, M. Gottfried, Ronald Burkes, M. Voi, P. Weynants, Frances A. Shepherd, H CortesFunes, R Rosso, Maurizio Tonato, B Cottier
Publikováno v:
European Journal of Cancer, 32A(2), 243-248. ELSEVIER SCI LTD
Gemcitabine is a novel nucleoside analogue with activity in solid tumours. This study assessed the objective response rate to gemcitabine given weekly intravenously at a dose of 1250 mg/m(2) for 3 weeks followed by 1 week of rest (one cycle) in chemo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ebdf7775029193f997022ce50ac40cf1
https://pubmed.ncbi.nlm.nih.gov/8664035
https://pubmed.ncbi.nlm.nih.gov/8664035
Autor:
P I, Clark, B, Cottier
Publikováno v:
Seminars in oncology. 19(6 Suppl 14)
Pharmacologic studies in patients with small cell lung cancer treated with differing schedules of intravenous etoposide over 1 to 8 days have suggested that etoposide's antitumor cytotoxicity is related to duration of exposure to low plasma levels of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::eb0af2de0de24c78421bb993332d91f1
https://pubmed.ncbi.nlm.nih.gov/1336898
https://pubmed.ncbi.nlm.nih.gov/1336898